Search Results for: masayo takahashi

Flash stem cell contest: free passes to see Yamanaka & more at WAFSF meeting in SFO

/ / 2 Comments
World-Alliance-Forum-San-Francisco

One of the best stem cell meetings each year is the World Alliance Form San Francisco (WAFSF) stem cell conference, where Shinya Yamanaka will be speaking. It brings together in San Francisco many of the very best stem cell researchers from around the world doing the most cutting edge translational research. You should go! The speakers […]

Flash stem cell contest: free passes to see Yamanaka & more at WAFSF meeting in SFO Read More »

Shinya Yamanaka Interview on Clinical Use of IPSC

/ / 10 Comments
Dr.-ShinyaYamanaka

I invited Nobel Laureate Shinya Yamanaka to do an interview on the future of clinical translation of induced pluripotent stem cells (iPSC). He provides some intriguing new insights into the iPSC field and the broader stem cell arena. PK: The Takahashi Team’s active Clinical Study using iPSCs to make RPEs to treat Macular Degeneration has

Shinya Yamanaka Interview on Clinical Use of IPSC Read More »

Stem Cell Person of the Year 2014 Award: Vote To Choose 12 Finalists

/ / 4 Comments
Stem-Cell-Symbol

Nominations have closed and we have more than two dozen nominations for Stem Cell Person of the Year 2014. It’s an exciting, diverse group including some news faces as well as nominees from years past as well. Happy Stem Cell Day! You can now vote for your choice for the top finalists in the poll

Stem Cell Person of the Year 2014 Award: Vote To Choose 12 Finalists Read More »

BioTime Cell Cure Files IND with FDA for ES cell AMD therapy

/ / 2 Comments
Cell-Cure-Logo

Stem cell biotech BioTime announced the news today that its subsidiary Cell Cure Neurosciences (Cell Cure) has filed an IND with the FDA for an embryonic stem (ES) cell-based therapy for Dry age-related macular degeneration (AMD). The product to be tested is OpRegen, which the company indicates is “the first IND for an ES cell-based

BioTime Cell Cure Files IND with FDA for ES cell AMD therapy Read More »

Landmark: patient receives first ever iPS cell based transplant

/ / 10 Comments
Masayo-Takahashi-150x150

In a major first for the stem cell and regenerative medicine fields, a patient in Japan today received a pioneering transplant of a retinal pigmented epithelial (RPE) sheet made from induced pluripotent stem (iPS) cells, also known by the acronym IPSC. This is the first ever iPS cell-based transplant into a human. The patient is

Landmark: patient receives first ever iPS cell based transplant Read More »

Cool, encouraging new preclinical study on monkey stem cells

/
monkey-iPSC-tumors

What happens if we start using induced pluripotent stem (iPS) cells clinically in humans? A cool new paper recently came out that gets us closer to being able to predict an answer. It’s an important question as iPS cell-derived cellular products are getting closer to clinical use. For example, the first iPS cell-based clinical trial

Cool, encouraging new preclinical study on monkey stem cells Read More »

Nominees for Stem Cell Person of the Year 2013: scientists, advocates, physicians, and the Pope

/ / 3 Comments

Nominations for Stem Cell Person of the Year 2013 closed last night and I ended up with a remarkable list of 30 nominees. I have included a few sentences about each one below, often taking verbiage directly from the nominator. The online voting on these nominees will start soon. The top vote getters will move

Nominees for Stem Cell Person of the Year 2013: scientists, advocates, physicians, and the Pope Read More »